Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Julian Brody

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, corporate, corporate and capital markets
Office
San Diego
Active in the record
2021 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPODebt Capital MarketsJoint VentureM&A
Sectors
Healthcare & Life SciencesTechnology
Jurisdictions
United States

Recent deals

12 announced deals in the record
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 446m
Latham & Watkins Advises AMD in US$4.75 Billion Senior Notes Offering 15 Aug 2026
Debt Capital Markets Technology Latham & Watkins LLP USD 4.75bn corporate
Latham Represents Penguin Solutions in US$650 Million Convertible Senior Notes Offering and Refinancing 16 Jul 2026
Debt Capital Markets Technology Latham & Watkins LLP USD 650m corporate
Latham & Watkins Advises Health Catalyst on Divestiture of Vitalware 8 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP corporate and capital markets
Latham & Watkins Represents Cerebras Systems Inc. in US$5.55 Billion IPO 19 May 2026
Capital Markets & IPO Technology Latham & Watkins LLP USD 5.55bn corporate
Latham & Watkins Advises Wolfspeed on Sale of US$379 Million of Convertible Notes and US$96.9 Million of Common Stock and Pre‑Funded Warrants 27 Mar 2026
Capital Markets & IPO Latham & Watkins LLP corporate
Latham & Watkins Advises on Immunome’s Upsized Public Offering of Common Stock 30 Jan 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m capital markets
Latham & Watkins Advises on CG Oncology’s Public Offering 14 Dec 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 204m
Latham Advises Health Catalyst in Secured Growth Financing 19 Jul 2024
Banking & Finance Healthcare & Life Sciences Latham & Watkins LLP USD 225m corporate
Latham & Watkins Advises on Structure Therapeutics’ US$300 Million Private Placement Equity Financing 30 Sept 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 300m capital markets
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Julian Brody is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 12 deals for Julian Brody

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction